InsidersTradesSigma
Follow the Palomino Laboratories Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on US US, under the oversight of SEC (Form 4). The latest transaction was disclosed on 20 April 2026 (Acquisition). Among the most active insiders: Denbaars Steven. All data is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations
Palomino Laboratories Inc. is a company listed on the XNAS market, specializing in the development of pharmaceutical solutions. It focuses on innovation and research in the field of medical laboratories.